C WorldWide Group Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$22.1M |
| 2 |
Aon
AON
|
+$17.3M |
| 3 |
Ionis Pharmaceuticals
IONS
|
+$14.4M |
| 4 |
Insulet
PODD
|
+$8.58M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$4.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$97.4M |
| 2 |
Visa
V
|
+$75.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$64.9M |
| 4 |
Amazon
AMZN
|
+$59.5M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$57.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.28% |
| 2 | Financials | 21.4% |
| 3 | Healthcare | 17.69% |
| 4 | Consumer Staples | 10.07% |
| 5 | Consumer Discretionary | 8.46% |
Similar funds
C WorldWide Group's Q4 2023 Portfolio in Review
As of Q4 2023, C WorldWide Group held 89 positions worth $7.45B, up 1.8% from $7.32B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
C WorldWide Group withdrew a net $661M in Q4 2023, closing 5 positions and reducing 34 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
Against the trend, C WorldWide Group opened a new position in Medtronic worth $23.9M.
- C WorldWide Group's largest Q4 2023 buy was Medtronic: 290,000 shares worth $23.9M.
- C WorldWide Group added most to Aon in Q4 2023, an estimated $17.3M increase.
- C WorldWide Group's biggest Q4 2023 reduction was Microsoft, cutting an estimated $97.4M.
- C WorldWide Group fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $36M.
- C WorldWide Group's ten largest holdings make up 67% of its $7.45B portfolio in Q4 2023.
- C WorldWide Group opened 4 new positions and closed 5 in Q4 2023.
- C WorldWide Group's portfolio value rose 1.8% quarter-over-quarter to $7.45B.
Based on C WorldWide Group's 13F filing for Q4 2023, filed 5 Feb 2024.